NuGen Medical Devices Inc. (TSXV:NGMD)

Market Cap	12.49M
Revenue (ttm)	1.08M
Net Income (ttm)	-1.83M
Shares Out	227.04M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,000
Average Volume	59,728
Open	0.0550
Previous Close	0.0550
Day's Range	0.0550 - 0.0600
52-Week Range	0.0400 - 0.1550
Beta	2.18
RSI	41.91
Earnings Date	Aug 29, 2025

About NuGen Medical Devices

NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, Vaccines, Veterinary, Home healthcare, and others. It also provides InsuJet that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is headquartered i...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Lin Liang
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: NGMD

Financial Performance

In 2024, NuGen Medical Devices's revenue was 1.01 million, an increase of 204.73% compared to the previous year's 331,403. Losses were -5.23 million, -44.18% less than in 2023.